The Rights Plan is similar to those adopted by other publicly traded companies. Pursuant to the Rights Plan, Nano Dimension will issue one special purchase right for every one ADS outstanding at the close of business on February 6, 2023. Each right will allow its holder to purchase from Nano Dimension one-half of one (0.5) ADS, at a purchase price of $0.01 per ADS, once the rights become exercisable. The rights would become exercisable only if an entity, person or group acquires beneficial ownership of 10% or more of Nano Dimension’s outstanding ordinary shares in a transaction not approved by the Company’s Board. The Rights will expire on January 27, 2024.
NewAmsterdam Pharma Reports FY22 Financial Results And Provides Corporate Update; FY22 EPS €(0.96) Vs €(1.19) YoY; FY22 Revenue €98M
Full Year 2022 Financial Results
Cash Position: As of December 31, 2022, NewAmsterdam had cash of €439 million, compared to €53 million as of December 31, 2021. The increase in cash was
